Medicare Advantage vs. Medicare FFS: Chronic Conditions Outcomes

      
HealthcareWebSummit
 
Home Page  | Upcoming Events  |  Past Events  |  Registration  |   Attendees  |  More Info  |  LinkedIn | Privacy
 
Medicare Advantage vs. Medicare FFS: Chronic Conditions Outcomes 
 
  Download Brochure Need a Printable Form? Download the event flyer including a registration form you can fax or mail
     
Overview
The clinical characteristics and care needs of older adults are changing over time. More than half of the Medicare population has 4 or more chronic conditions. Effectively managing the delivery of care for Medicare beneficiaries with multiple chronic conditions has the potential to improve the quality of life for these beneficiaries while reducing Medicare spending. To date, there is little comprehensive information on the performance and value of Medicare Advantage compared to FFS Medicare, due in part to a lack of access to Medicare Advantage data comparable to that available for FFS Medicare.

The Better Medicare Alliance sponsored an Avalere study to compare demographic and clinical characteristics, overall healthcare utilization, cost of care, and related clinical quality outcomes in 2 large national samples of Medicare Advantage and FFS Medicare beneficiaries enrolled for the full year of 2015. Avalere selected beneficiaries with 1 or more of 3 of the top-5 most prevalent chronic conditions in the Medicare population: hypertension, hyperlipidemia, and diabetes.

A descriptive cross-sectional cohort design was used to analyze a sample of 1,581,822 MA beneficiaries extracted from Inovalonís MORE2 Registry and a sample of 1,212,698 FFS beneficiaries extracted from Medicare Standard Analytical Files enrolled for the full year in 2015. Costs were calculated using published Medicare standard rates to enable direct comparison of spending by expenditure category in MA and FFS Medicare.

The study found that Medicare Advantage has a higher proportion of patients with clinical and social risk factors shown to affect health outcomes and cost than FFS Medicare; and that despite a higher proportion of clinical and social risk factors, Medicare Advantage beneficiaries with chronic conditions experienced lower utilization of high-cost services, comparable average costs, and better outcomes.

Please join us on Tuesday September 18, 2018, at 1 PM Eastern as Avalere's Christie Teigland, PhD and Better Medicare Alliance's James Michel present Avalere's research findings and perspectives in the HealthcareWebSummit event: Medicare Advantage vs. Medicare FFS: Chronic Conditions Outcomes.
Learning Objectives

After attending this webinar, attendees will be able to:

  1. Identify key findings from Avalere research comparing Medicare Advantage to Medicare Fee For Service regarding chronic condition patient outcomes.
  2. Examine comparative research data compiled from the study regarding beneficiary characteristics, healthcare utilization and costs, and healthcare quality indicators.
  3. Evaluate the performance of Medicare Advantage dual eligibles vs. Medicare FFS dual eligibles in the study population.
  4. Consider the outcomes of the most complex cohort - diabetes, with more than 75% of MA and FFS Medicare diabetes patients having all 3 chronic conditions (referred to as the clinically complex diabetes cohort.)
  5. Understand the relevant aspects of the study methodology, including objectives, study design, cohort selection, and data analysis .
  6. Engage in interactive learning through online question submission, attendee feedback and opportunity for follow up questions, and networking with attendees, faculty and other professionals through dedicated LinkedIn group.
Who Should Attend

Interested attendees would include:

  • C-Suite Executives
  • Medicare Program Executives and Staff
  • Medical Directors
  • Population Health Executives and Staff
  • Analytics Executives and Staff
  • Managed Care Executives and Staff
  • Revenue Cycle Executives and Staff
  • Planning and Strategic Executives and Staff
  • Legal, Regulatory and Policy Executives and Staff
  • Business Intelligence Staff
  • Other Interested Parties

Attendees would represent organizations including:

  • Health Plans
  • Provider Networks
  • ACOs
  • Hospitals and Health Systems
  • PBMs
  • Government Agencies
  • Life Sciences Organizations
  • Solutions Providers
  • Associations, Institutes and Research Organizations
  • Media
  • Other Interested Organizations
Registration
  Individual Registration Fee: $195. Post-event materials, with video of slides synchronized with speaker audio, plus presentation pdf file: $45 for attendees; $260 for non-attendees after the event. Register online or download the event flyer.
 
 
 
Register Now   Click here to register or call 209.577.4888. Corporate Site licensing also available. We look forward to your attendance!
 
 
Faculty
 
Christie Teigland, PhD

Christie Teigland, PhD
Vice President
Avalere Health

  Christie Teigland, PhD, Vice President, leads the design and implementation of studies focused on comparative effectiveness, predictive analytics, and performance measure development and testing. With a focus on improving quality in healthcare through data analytics, she provides clients with actionable insight and analysis.

Prior to joining Avalere, Christie was the Senior Director, Statistical Research, at Inovalon, where she led a team focused on healthcare data analytics. She led several performance measure development projects awarded by the National Committee on Quality Assurance (NCQA), including All-Cause Readmissions and Potentially Avoidable Hospitalizations. Prior to joining Inovalon, she specialized in quality measurement and quality improvement research at Leading Age New York, where she directed the development of innovative technology solutions to advance the use of data-driven decision making to improve outcomes and reduce healthcare costs.

Christie earned a PhD in Economics and Econometric Forecasting from the University at Albany, SUNY, and a BA in Management Science and Economics from Minnesota State University.


 
James Michel

James Michel 
Director of Policy at Better Medicare Alliance

   
James Michel is the Director of Policy at Better Medicare Alliance and has almost 10 years in health care policy analysis and consulting.

Prior to BMA, James was a Senior Director at the American Health Care Association, the nationís largest trade association representing post-acute and long-term care providers, where he managed much of the associationís Medicare and health information technology policy analysis and research.

Before that, he worked for Booz Allen Hamilton and the Advisory Board Company, two leading, DC-based health care consulting firms. James holds a Bachelor of Science degree in neuroscience from the University of Michigan Ė Ann Arbor.

 
HealthcareWebSummit events from MCOL  
1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888  | e-Mail
infohws@healthwebsummit.com  |  Fax 209.577.3557
copyright , MCOL All rights reserved. Terms of Use apply to this site and participation in events.